Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.

Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DX, Ellis SG, Forder JR, Anderson RD, Hatzopoulos AK, Penn MS, Perin EC, Chambers J, Baran KW, Raveendran G, Lambert C, Lerman A, Simon DI, Vaughan DE, Lai D, Gee AP, Taylor DA, Cogle CR, Thomas JD, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Kappenman C, Westbrook L, Piller LB, Simpson LM, Baraniuk S, Loghin C, Aguilar D, Richman S, Zierold C, Spoon DB, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN)
JAMA. 2012 308 (22): 2380-9

PMID: 23129008 · PMCID: PMC3652242 · DOI:10.1001/jama.2012.28726

MeSH Terms (12)

Aged Bone Marrow Transplantation Double-Blind Method Female Humans Magnetic Resonance Imaging Male Middle Aged Myocardial Infarction Time Factors Treatment Outcome Ventricular Dysfunction, Left

Connections (3)

This publication is referenced by other Labnodes entities: